|
|
Clinical and Economic Outcomes Attributable to Health Care–Associated Sepsis and Pneumonia |
Michael R. Eber, BSE Ramanan Laxminarayan, PhD, MPH Eli N. Perencevich, MD, MS Anup Malani, PhD, JD |
|
|
Increasing Resistance of Acinetobacter Species to Imipenem in United States Hospitals, 1999–2006 |
Marc S. Hoffmann, MD Michael R. Eber, BSE Ramanan Laxminarayan, PhD, MPH |
|
|
Community-associated Methicillin- Resistant Staphylococcus aureus in Outpatients, United States, 1999–2006 |
Eili Klein, David L. Smith, and Ramanan Laxminarayan |
|
|
Flu and Antibiotic Overprescription |
Hellen Gelband |
|
|
Battling Resistance to Antibiotics and Pesticides: An Economic Approach |
Ramanan Laxminarayan, editor |
|
|
A Shot Against MRSA? |
Hellen Gelband |
|
|
The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004 |
Rebecca Reik Fred C. Tenover Eili Klein L. Clifford McDonald |
|
|
Extending the CurePolicy Responses to the Growing Threat of Antibiotic Resistance |
Ramanan Laxminarayan Anup Malani |
|
|
Antibiotic OveruseThe Influence of Social Norms |
The McDonnell Norms Group Ramanan Laxminarayan Anup Malani et al. |
|
|
Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999-2005 |
Eili Klein David L. Smith Ramanan Laxminarayan |
|
|
The Antibiotic Pipeline |
Abigail Colson |
|
|
Which MRSA is it? |
Abigail Colson |
|
|
Legislative Roundup for 2007 |
Abigail Colson |
|
|
Counting MRSA CasesAn Evaluation of Recent Evidence |
Abigail Colson |
|
|
The States Take ActionHospital Infection Reporting and Control |
Abigail Colson |
